Your browser is no longer supported. Please, upgrade your browser.
Settings
GRFS Grifols, S.A. daily Stock Chart
GRFS [NASD]
Grifols, S.A.
Index- P/E33.97 EPS (ttm)0.60 Insider Own0.02% Shs Outstand700.59M Perf Week-2.51%
Market Cap14.17B Forward P/E13.05 EPS next Y1.55 Insider Trans0.00% Shs Float- Perf Month-0.39%
Income- PEG3.01 EPS next Q0.30 Inst Own69.32% Short Float- Perf Quarter-18.49%
Sales5.31B P/S2.67 EPS this Y44.30% Inst Trans- Short Ratio1.77 Perf Half Y-4.84%
Book/sh3.27 P/B6.20 EPS next Y10.70% ROA- Target Price24.50 Perf Year-4.17%
Cash/sh- P/C- EPS next 5Y11.30% ROE- 52W Range19.92 - 25.18 Perf YTD-11.74%
Dividend0.42 P/FCF- EPS past 5Y-5.01% ROI- 52W High-19.66% Beta-
Dividend %2.08% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low1.56% ATR0.46
Employees18300 Current Ratio- Sales Q/Q-2.80% Oper. Margin- RSI (14)38.67 Volatility1.73% 2.03%
OptionableYes Debt/Eq- EPS Q/Q65.70% Profit Margin- Rel Volume1.42 Prev Close20.16
ShortableYes LT Debt/Eq- EarningsMay 30 BMO Payout- Avg Volume626.93K Price20.23
Recom2.00 SMA20-2.40% SMA50-4.99% SMA200-7.30% Volume891,418 Change0.35%
Oct-31-17Initiated Citigroup Buy
Jun-30-17Downgrade Goldman Buy → Neutral
Apr-06-17Initiated BofA/Merrill Buy
Jan-03-17Upgrade JP Morgan Neutral → Overweight
Feb-09-16Upgrade Berenberg Hold → Buy
Jan-04-16Downgrade Morgan Stanley Equal-Weight → Underweight
Dec-02-15Downgrade HSBC Securities Buy → Hold
Nov-20-15Downgrade Berenberg Buy → Hold
Apr-28-15Downgrade Berenberg Buy → Hold
Apr-16-18 11:21AM  Grifols donates over 25 million international units of blood clotting factor in 2017 PR Newswire
Apr-13-18 06:19AM  With 21.50% Earnings Growth, Did Grifols SA. (BME:GRF) Outperform The Industry? Simply Wall St.
Apr-10-18 08:20AM  Report: Exploring Fundamental Drivers Behind Itau Unibanco Holding S.A, Weibo, Redhill Biopharma, Shenandoah Telecommunications, Grifols, S.A, and Orthofix International N.V New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Apr-06-18 10:40AM  Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018 PR Newswire
Mar-29-18 08:59AM  Estimating The Fair Value Of Grifols SA. (BME:GRF) Simply Wall St.
Mar-22-18 08:38AM  Is It Time To Buy Grifols SA. (BME:GRF) Based Off Its PE Ratio? Simply Wall St.
Mar-15-18 06:50AM  Can Grifols SA. (BME:GRF) Continue To Outperform Its Industry? Simply Wall St.
Mar-14-18 02:50PM  Grifols breaks ground on $120M Clayton facility American City Business Journals
Mar-13-18 08:00AM  Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V.  Fundamental Analysis, Key Performance Indications GlobeNewswire
Mar-06-18 09:42AM  Henry Schien to Distribute Grifols Product in United States Zacks
Mar-05-18 09:00AM  Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S. PR Newswire
Feb-28-18 10:05AM  Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD" PR Newswire
Feb-06-18 09:45AM  Grifols HyperRAB® (rabies immune globulin ) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection PR Newswire
Jan-03-18 03:00AM  Stocks With Rising Relative Price Strength: Grifols Investor's Business Daily
Dec-19-17 01:09PM  ETFs with exposure to Grifols SA : December 19, 2017 Capital Cube
Dec-11-17 12:06PM  Grifols SA : GRFS-US: Dividend Analysis : December 04th, 2017 (record date) : By the numbers : December 11, 2017 Capital Cube
Dec-05-17 12:54PM  ETFs with exposure to Grifols SA : December 5, 2017 Capital Cube
Dec-04-17 08:00AM  Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation PR Newswire
Nov-16-17 11:39AM  ETFs with exposure to Grifols SA : November 16, 2017 Capital Cube
Nov-02-17 12:11PM  ETFs with exposure to Grifols SA : November 2, 2017 Capital Cube
Oct-31-17 03:00AM  Stocks Showing Rising Market Leadership: Grifols Earns 83 RS Rating Investor's Business Daily +5.35%
Oct-23-17 10:40AM  ETFs with exposure to Grifols SA : October 23, 2017 Capital Cube
Oct-10-17 11:29AM  ETFs with exposure to Grifols SA : October 10, 2017 Capital Cube
Oct-09-17 09:51AM  Grifols SA :GRFS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 9, 2017 Capital Cube
Sep-20-17 09:30AM  Should Value Investors Consider Grifols (GRFS) Stock Now? Zacks
Sep-13-17 11:25AM  3 Pharma/Biotech Sector Bargains for a Healthy Portfolio Zacks
Sep-06-17 03:00AM  Grifols Shows Market Leadership With Jump To 82 RS Rating Investor's Business Daily
Aug-29-17 12:31PM  Grifols Is a Leader in High-Demand Plasma GuruFocus.com
Aug-28-17 03:00AM  Stocks Flashing Renewed Technical Strength: Grifols Investor's Business Daily
Aug-22-17 08:00AM  Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces PR Newswire
Aug-01-17 08:00AM  Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol PR Newswire
Jun-22-17 03:11PM  Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples PR Newswire
Jun-21-17 03:48PM  When 'New' Means A Stock Hasn't Led The Market In A While Investor's Business Daily
Jun-16-17 09:55AM  Should Value Investors Consider Grifols (GRFS) Stock Right Now? Zacks
Jun-12-17 04:00AM  Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement PR Newswire
May-31-17 11:02AM  Grifols SA : GRFS-US: Dividend Analysis : June 01st, 2017 (record date) : By the numbers : May 31, 2017 Capital Cube
May-10-17 04:45PM  Hologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents Investor's Business Daily
May-09-17 10:00AM  Investigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US PR Newswire
May-04-17 10:37AM  VIVUS (VVUS) Loss Narrower than Expected, Revenues Up Y/Y Zacks
Apr-27-17 04:37PM  Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View Zacks
11:11AM  Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View Zacks
Apr-24-17 08:00AM  Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility PR Newswire
Apr-20-17 10:30AM  Nivalis' (NVLS) Shares Down After Merger Deal with Alpine Zacks
08:15AM  GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1% Zacks
Apr-19-17 02:06PM  How to Uncover Institutional Buying Zacks
01:32PM  Can young blood pump new life into treatments for diseases of aging? American City Business Journals
Apr-17-17 09:00AM  Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program PR Newswire
Apr-05-17 11:20AM  Amgen Files for Xgeva Label Expansion, To Include Myeloma Zacks
11:20AM  Amgen Files for Xgeva Label Expansion, To Include Myeloma
Apr-04-17 09:19AM  Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk Zacks
09:11AM  Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 PR Newswire
09:11AM  Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017
Apr-01-17 12:12PM  New Breakout Stocks Zacks Rank #1 (Strong Buy) Zacks
12:12PM  New Breakout Stocks Zacks Rank #1 (Strong Buy)
Mar-31-17 08:41AM  AbbVie's (ABBV) Humira Drug Label Update Approved by FDA Zacks
08:41AM  AbbVie's (ABBV) Humira Drug Label Update Approved by FDA
Mar-30-17 10:51AM  New Strong Buy Stocks for March 30th Zacks
10:51AM  New Strong Buy Stocks for March 30th
Mar-28-17 08:15AM  Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2% Zacks
08:15AM  Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%
Mar-22-17 08:19AM  5 Cheap PEG Picks for Value Investors Right Now
Mar-21-17 02:58PM  Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod Zacks
02:58PM  Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar-20-17 10:32AM  AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal Zacks
10:32AM  AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar-17-17 09:50AM  Is Grifols a Great Stock for Value Investors?
Mar-10-17 08:15AM  Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session
Mar-09-17 09:27AM  New Strong Buy Stocks for March 9th
08:15AM  Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%
Mar-07-17 05:48PM  5 European Stocks to Buy as Trump Rally Weakens
Mar-06-17 12:24PM  Grifols SA :GRFS-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017
Mar-03-17 10:46AM  Grifols SA :GRFS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017
Mar-02-17 08:15AM  Blog Coverage Kite Pharma CAR-T Cancer Therapy Demonstrate Positive Results in B-cell non-Hodgkin Lymphoma Accesswire
Jan-31-17 04:05PM  Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire
04:01PM  Hologic Completes Divestiture of Blood Screening Business PR Newswire
Jan-30-17 12:26PM  Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017
Jan-03-17 11:51AM  Grifols, S.A. upgraded by JP Morgan
Dec-19-16 07:46AM  Hologic (HOLX) to Divest Blood Screening Business to Grifols
Dec-15-16 04:42PM  Hologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit +6.99%
Dec-14-16 07:14PM  Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B
04:43PM  Hologic to sell stake in blood screening unit for $1.85 bln at MarketWatch
04:15PM  Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire
04:01PM  Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion PR Newswire
Dec-13-16 12:56PM  ETFs with exposure to Grifols SA : December 13, 2016
Dec-09-16 06:52PM  Virgin America Inc (VA): Is It Right For Your Portfolio? at Insider Monkey
Dec-05-16 06:45AM  Ligand Pharmaceuticals Inc. (LGND): Hedge Fund Sentiment Unchanged at Insider Monkey
Dec-02-16 12:29PM  ETFs with exposure to Grifols SA : December 2, 2016
Dec-01-16 04:29PM  John Paulson's Largest 3rd Quarter Trades
Nov-25-16 10:10PM  What Explains the Huge Jump in Louisiana-Pacific Corporation (LPX)s Hedge Fund Ownership? at Insider Monkey
Nov-11-16 10:11AM  Grifols SA :GRFS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
Oct-20-16 07:37PM  The CLIA Lab at the Grifols Immunohematology Center Will Now Offer Both Serology and Molecular Tests Business Wire
Oct-07-16 11:14AM  Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : October 7, 2016
Sep-08-16 07:39AM  5 Big Dividend Stocks Billionaire John Paulson Loves
Sep-07-16 07:04PM  Why Is JOHIX Doing So Well Year-to-Date?
Sep-05-16 05:32AM  Grifols Opens Diagnostic Training Center in Dubai PR Newswire
Aug-26-16 04:38PM  New Zika Screening Rule Could Boost Hologic Sales Growth
Aug-25-16 10:16AM  ETFs with exposure to Grifols SA : August 25, 2016
Jul-26-16 11:01AM  Grifols SA :GRFS-US: Earnings Analysis: Q1, 2016 By the Numbers : July 26, 2016
Jul-25-16 01:29PM  ETFs with exposure to Grifols SA : July 25, 2016
Jul-12-16 12:20PM  Grifols SA : GRFS-US: Dividend Analysis : June 06th, 2016 (record date) : By the numbers : July 12, 2016
Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use, including the reception, analysis, quarantine, classification, fractionation, and purification of plasma; and sells and distributes end products. It offers plasma products, such as intravenous immune globulin, Factor VIII, alpha-1 proteinase inhibitor, and albumin; and intramuscular immunoglobulins, antithrombin III, Factor IX, and plasma thromboplastin components. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products comprising analytical instruments, reagents, software, and related products for use in clinical and blood bank laboratories. It serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital segment offers products used by hospitals, as well as parenteral solutions and enteral nutritional fluids. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides infusion solutions, nutrition products, and medical devices for use in hospitals and clinics; and engineering services. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves hospitals and clinics, group purchasing organizations, governments, and other distributors through sales representatives, marketing partners, and third-party distributors. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.